Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score

Abroad (travel likely)RecruitingPHASE4

Conditions

Heart Failure With Reduced Ejection Fraction

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Jamine Luzman, PharmD, PhD) · jluzum@med.umich.edu · 734-615-4851
Contact: Principal Investigator (Jasmine Luzum, PharmD, PhD)

Study leads

Jasmine Luzum, PharmD, PhD
Principal Investigator
University of Michigan

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

Heart Failure With Reduced Ejection Fraction (HFrEF) · Sudden Cardiac Death · Ventricular Arrhythmia

Abroad (travel likely)RecruitingPHASE4

Scottsdale, United States · Rome, United States

ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Aortic Valve Stenosis · Heart Failure

Abroad (travel likely)RecruitingPHASE4

Bucheon-si, South Korea · Changwon, South Korea

SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction

Heart Failure

Abroad (travel likely)RecruitingPHASE4

Beijing, China · Beijing, China

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

Heart Failure with Reduced Ejection Fraction · End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE4

Hsinchu, Taiwan · Taipei, Taiwan